Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Drug Deliv ; 13(3): 471-80, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26568138

RESUMO

Aloe vera is a plant with a long history of traditional medicinal use and is consumed in different products, sometimes in conjunction with prescribed medicines. A. vera gel has shown the ability to modulate drug absorption in vitro. The aim of this study was to fractionate the precipitated polysaccharide component of A. vera gel based on molecular weight and to compare their interactions with indinavir pharmacokinetics. Crude polysaccharides were precipitated from a solution of A. vera gel and was fractionated by means of centrifugal filtration through membranes with different molecular weight cut-off values (i.e. 300 KDa, 100 KDa and 30 KDa). Marker molecules were quantified in the aloe leaf materials by means of nuclear magnetic resonance spectroscopy and the average molecular weight was determined by means of gel filtration chromatography linked to multi-angle-laser-light scattering and refractive index detection. The effect of the aloe leaf materials on the transepithelial electrical resistance (TEER) of Caco-2 cell monolayers as well as indinavir metabolism in LS180 cells was measured. The bioavailability of indinavir in the presence and absence of the aloe leaf materials was determined in Sprague-Dawley rats. All the aloe leaf materials investigated in this study reduced the TEER of Caco-2 cell monolayers, inhibited indinavir metabolism in LS 180 cells to different extents and changed the bioavailability parameters of indinavir in rats compared to that of indinavir alone. These indinavir pharmacokinetic modulation effects were not dependent on the presence of aloverose and also not on the average molecular weight of the isolated fractions.


Assuntos
Aloe , Inibidores da Protease de HIV/farmacocinética , Indinavir/farmacocinética , Preparações de Plantas/química , Polissacarídeos/farmacologia , Animais , Disponibilidade Biológica , Células CACO-2 , Linhagem Celular , Humanos , Masculino , Folhas de Planta/química , Polissacarídeos/isolamento & purificação , Ratos Sprague-Dawley
2.
Drug Deliv ; 23(2): 631-41, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-25005585

RESUMO

CONTEXT: Viral and fungal cutaneous manifestations are regularly encountered in immunocompromised human immunodeficiency virus/acquired immunodeficiency syndrome individuals and can be treated by drugs such as acyclovir and ketoconazole, respectively. OBJECTIVE: The aim of this study was to determine whether the novel Pheroid delivery system improved the transdermal delivery and/or dermal delivery of acyclovir and ketoconazole when incorporated into semi-solid formulations. MATERIALS AND METHODS: Semi-solid products (creams and emulgels) containing these drug compounds were formulated, either with or without (control) the Pheroid delivery system. The stability of the formulated semi-solid products was examined over a period of six months and included the assay of the actives, pH, viscosity, mass loss and particle size observation. Vertical Franz cell diffusion studies and tape stripping methods were used to determine the in vitro, stratum corneum (SC)-epidermis and epidermis-dermis delivery of these formulations. RESULTS AND DISCUSSION: Stability tests showed that none of the formulations were completely stable. Acyclovir showed a biphasic character during the in vitro skin diffusion studies for all the tested formulations. The Pheroid™ cream enhanced the transdermal, SC-epidermis and epidermis-dermis delivery of acyclovir the most. The average amount of ketoconazole diffused over 12 h showed improved delivery of ketoconazole, with the Pheroid™ emulgel exhibiting the best transdermal and epidermis-dermis delivery. CONCLUSION: The Pheroid formulae increased transdermal penetration as well as delivery to the dermal and epidermal skin layers. The Pheroid emulgel and the Pheroid cream increased the topical delivery of ketoconazole and acyclovir, respectively.


Assuntos
Aciclovir/administração & dosagem , Antifúngicos/administração & dosagem , Antivirais/administração & dosagem , Portadores de Fármacos , Ácidos Graxos/química , Cetoconazol/administração & dosagem , Aciclovir/química , Administração Cutânea , Antifúngicos/química , Antivirais/química , Difusão , Composição de Medicamentos , Estabilidade de Medicamentos , Armazenamento de Medicamentos , Feminino , Géis , Humanos , Concentração de Íons de Hidrogênio , Técnicas In Vitro , Cetoconazol/química , Óxido Nitroso/química , Pomadas , Tamanho da Partícula , Pele/metabolismo , Absorção Cutânea , Solubilidade , Tecnologia Farmacêutica/métodos , Viscosidade
3.
Eur J Drug Metab Pharmacokinet ; 41(5): 575-86, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25939330

RESUMO

Currently, macromolecular drugs such as proteins are mainly administered by means of injections due to their low intestinal epithelial permeability and poor stability in the gastrointestinal tract. This study investigated binary combinations of chemical drug absorption enhancers to determine if synergistic drug absorption enhancement effects exist. Aloe vera, Aloe ferox and Aloe marlothii leaf gel materials, as well as with N-trimethyl chitosan chloride (TMC), were combined in different ratios and their effects on the transepithelial electrical resistance (TEER), as well as the transport of FITC-dextran across Caco-2 cell monolayers, were measured. The isobole method was applied to determine the type of interaction that exists between the absorption enhancers combinations. The TEER results showed synergism existed for the combinations between A. vera and A. marlothii, A. marlothii and A. ferox as well as A. vera and TMC. Antagonism interactions also occurred and can probably be explained by chemical reactions between the chemical permeation enhancers, such as complex formation. In terms of FITC-dextran transport, synergism was found for combinations between A. vera and A. marlothii, A. marlothii and A. ferox, A. vera and TMC, A. ferox and TMC and A. marlothii and TMC, whereas antagonism was observed for A. vera and A. ferox. The combinations where synergism was obtained have the potential to be used as effective drug absorption enhancers at lower concentrations compared to the single components.


Assuntos
Quitosana/metabolismo , Dextranos/metabolismo , Sinergismo Farmacológico , Fluoresceína-5-Isotiocianato/análogos & derivados , Absorção Intestinal/efeitos dos fármacos , Extratos Vegetais/metabolismo , Aloe/química , Transporte Biológico/efeitos dos fármacos , Células CACO-2 , Linhagem Celular Tumoral , Quitosana/administração & dosagem , Portadores de Fármacos/química , Portadores de Fármacos/metabolismo , Impedância Elétrica , Fluoresceína-5-Isotiocianato/metabolismo , Humanos , Permeabilidade , Extratos Vegetais/administração & dosagem , Folhas de Planta/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...